Clinical trialNAUnknown
Silicon Microsieve Device vs Cell Surface Marker-based Platform for the Isolation of Pancreatic Cancer CTCs
A Head-to-head Comparison of a Novel Silicon Microsieve Device Against a Cell Surface Marker-based Platform for the Isolation of Portal Vein Circulating Tumor Cells in Pancreatic Cancer
- Outcome
- Outcome unknown
- Phase
- NA
- Status
- Unknown
- Study type
- Interventional
- Start
- 17 November 2020
- Expected end
- 31 December 2021
- Enrollment
- 26 participants
- Sites
- 0
- Primary outcomes
- Number of circulating tumor cells
- Sponsor
- Other
- Results posted
- No
- Last update
- 23 November 2020
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Papers 4
- BackgroundA High Circulating Tumor Cell Count in Portal Vein Predicts Liver Metastasis From Periampullary or Pancreatic Cancer: A… DOI 10.1097/md.0000000000003407↗
- BackgroundAcquisition of Portal Venous Circulating Tumor Cells From Patients With Pancreaticobiliary Cancers by Endoscopic Ultras… DOI 10.1053/j.gastro.2015.08.050↗
- BackgroundLabel-free isolation of circulating tumor cells in microfluidic devices: Current research and perspectives. DOI 10.1063/1.4780062↗
- BackgroundReassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. DOI 10.1158/0008-5472.can-06-0410↗